| Yang, Yuhong; Xu, Yuanyuan; Yue, Yuan; Wang, Heng; Cui, Yumeng et al. (2021). Investigate Natural Product Indolmycin and the Synthetically Improved Analogue Toward Antimycobacterial Agents. ACS Chemical Biology 17(1) , 39-53. 10.1021/acschembio.1c00394. [PDB: 7ent, 7ev3] |
CMCF-ID |
Peer-Reviewed Article |
Health |
| Yang, Zemin; Johnson, Bryan A.; Meliopoulos, Victoria A.; Ju, Xiaohui; Zhang, Peipei et al. (2023). Interaction between host G3BP and viral nucleocapsid protein regulates SARS-CoV-2 replication. npj Computational Materials . 10.1101/2023.06.29.546885. [PDB: 8th7] |
CMCF-ID |
Peer-Reviewed Article |
Health |
| Ye, Qilu; Eves, Robert; Vance, Tyler D. R.; Hansen, Thomas; Sage, Adam P. et al. (2025). Aeromonas hydrophila
RTX adhesin has three ligand-binding domains that give the bacterium the potential to adhere to and aggregate a wide variety of cell types. mBio 16(5) . 10.1128/mbio.03158-24. [PDB: 9cse] |
CMCF-ID |
Peer-Reviewed Article |
Health |
| Zheng, Xiaozhang; Ji, Nan; Campbell, Veronica; Slavin, Anthony; Zhu, Xiao et al. (2024). Discovery of KT-474─a Potent, Selective, and Orally Bioavailable IRAK4 Degrader for the Treatment of Autoimmune Diseases. Journal of Medicinal Chemistry . 10.1021/acs.jmedchem.4c01305. [PDB: 9cuo] |
CMCF-ID |
Peer-Reviewed Article |
Health |
| Zhu, Yuao; Yurgelonis, Irina; Noell, Stephen; Yang, Qingyi; Guan, Shunjie et al. (2024). In vitro selection and analysis of SARS-CoV-2 nirmatrelvir resistance mutations contributing to clinical virus resistance surveillance. Science Advances 10(30) . 10.1126/sciadv.adl4013. [PDB: 9aum] |
CMCF-ID |
Peer-Reviewed Article |
Health |
| Scire, Michelle Denise (2021). Structure and Function of MUC1 Specific Monoclonal Antibodies. Supervisor: Brooks, Cory L.. California, United States: California State University, Fresno. https://www.proquest.com/openview/5490f79cdbfb3740264d2fb8533321b1/. |
CMCF-ID |
Masters Thesis |
Health |
| Binh Vu; Andrew Good (2023). Uses of p53 x-ray co-crystal structures. Patent Number: US20230024905A1. |
CMCF-ID |
Patent |
Health |
| Christopher W. DAVIES; Nobuhiko Kayagaki; James T. Koerber (2023). Anti-cleaved icaspase substrate antibodies and methods of use. Patent Number: EP4229093A1. |
CMCF-ID |
Patent |
Health |
| Han Li; Dorothea Kominos; Jie Zhang; Alla Pritsker; Matthew Davison et al. (2023). Methods for treating inflammation using antibodies to kallidin and des-arg10-kallidin. Patent Number: US20230399388A1. |
CMCF-ID |
Patent |
Health |
| Hedda WARDEMANN; Rajagopal Murugan; Tizian Decker; Eiena Levashina; Giulia COSTA et al. (2022). Plasmodium antibodies. Patent Number: US20220396614A1. |
CMCF-ID |
Patent |
Health |
| Jason Chin; Nicolas HUGUENIN-DEZOT; Mohan MAHESH; Shan Tang; Duy P. Nguyen et al. (2022). Methods and compositions. Patent Number: US20220010296A1. |
CMCF-ID |
Patent |
Health |
| Jean-Philippe Julien; Taylor Sicard; Anthony Semesi; Bebhinn Treanor; Tiantian Zhao et al. (2025). Nanoparticle platform for antibody and vaccine delivery. Patent Number: US20250114475A1. |
CMCF-ID |
Patent |
Health |
| Joan Seoane Suarez; Judit ANIDO FOLGUEIRA; Robin Matthew Hallett; Patricia Anne GIBLIN; Jeanne MAGRAM et al. (2021). Combination of lif inhibitors and platinum-based antineoplastic agents for use in treating cancer. Patent Number: US20210187106A1. |
CMCF-ID |
Patent |
Health |
| Joan Seoane Suarez; Judit ANIDO FOLGUEIRA; Robin Matthew Hallett; Peter Edward BAYLISS; Ajitha JEGANATHAN et al. (2021). Methods for improving response to anti-lif antibody treatment in individuals with cancer. Patent Number: US20210253691A1. |
CMCF-ID |
Patent |
Health |
| Judit Anido Folgueira; Patricia Anne Giblin; Robin Matthew Hallett; Jeanne Magram; Naimish PANDYA et al. (2024). Combination of lif inhibitors and platinum-based antineoplastic agents for use in treating cancer. Patent Number: AU2024204564A1. |
CMCF-ID |
Patent |
Health |